Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Eligible outpatients were adults (ages 18–55) with a principal diagnosis of OCD (⩾1 year), who were at least moderately symptomatic (Yale-Brown Obsessive-Compulsive Scale, Y-BOCS; Goodman et al, 1989b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback